Cargando…

Evaluating real-time internet therapy and online self-help for problematic alcohol consumers: a three-arm RCT protocol

BACKGROUND: Only a minority of all alcohol- and drug abusers is receiving professional care. In an attempt to narrow this treatment gap, treatment facilities experiment with online healthcare. Therefore, it is important to test the (cost-)effectiveness of online health interventions in a randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Blankers, Matthijs, Koeter, Maarten, Schippers, Gerard M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636801/
https://www.ncbi.nlm.nih.gov/pubmed/19144162
http://dx.doi.org/10.1186/1471-2458-9-16
Descripción
Sumario:BACKGROUND: Only a minority of all alcohol- and drug abusers is receiving professional care. In an attempt to narrow this treatment gap, treatment facilities experiment with online healthcare. Therefore, it is important to test the (cost-)effectiveness of online health interventions in a randomized clinical trial. METHODS: This paper presents the protocol of a three-arm randomized clinical trial to test the (cost-) effectiveness of online treatment for problem drinkers. Self-help online, therapy online and a waiting list are tested against each other. Primary outcome is change in alcohol consumption. Secondary outcome measures include quality of life and working ability. Incremental cost-effectiveness ratios for self-help online alcohol and therapy online alcohol will be calculated. The predictive validity of participant characteristics on treatment adherence and outcome will be explored. DISCUSSION: To our best knowledge, this randomized clinical trial will be the first to test the effectiveness of therapy online against both self-help online and a waiting-list. It will provide evidence on (cost-) effectiveness of online treatment for problem drinkers and investigate outcome predictors. TRIAL REGISTRATION: This trial is registered in the Dutch Trialregister (Cochrane Collaboration) and traceable as NTR-TC1155.